Asaf Danziger
2015
In 2015, Asaf Danziger earned a total compensation of $9.7M as Chief Executive Officer at NovoCure, a 453% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $478,772 |
|---|---|
| Option Awards | $8,263,713 |
| Salary | $642,111 |
| Other | $271,296 |
| Total | $9,655,892 |
Danziger received $8.3M in option awards, accounting for 86% of the total pay in 2015.
Danziger also received $478.8K in non-equity incentive plan, $642.1K in salary and $271.3K in other compensation.
Rankings
In 2015, Asaf Danziger's compensation ranked 553rd out of 13,638 executives tracked by ExecPay. In other words, Danziger earned more than 95.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 553 out of 13,638 | 96th |
Division Manufacturing | 189 out of 5,187 | 96th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 25 out of 754 | 97th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 16 out of 460 | 97th |
Industry Surgical and Medical Instruments and Apparatus | 6 out of 287 | 98th |
Source: SEC filing on March 28, 2017.
Danziger's colleagues
We found two more compensation records of executives who worked with Asaf Danziger at NovoCure in 2015.